Marshall Wace’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,716
| Closed | -$761K | – | 2828 |
|
|
2024
Q4 | $761K | Sell |
19,716
-295,657
| -94% | -$11.4M | ﹤0.01% | 1735 |
|
|
2024
Q3 | $14.2M | Sell |
315,373
-256,804
| -45% | -$11.6M | 0.02% | 571 |
|
|
2024
Q2 | $19.8M | Sell |
572,177
-404,716
| -41% | -$14M | 0.03% | 453 |
|
|
2024
Q1 | $28.3M | Buy |
976,893
+834,423
| +586% | +$24.1M | 0.04% | 348 |
|
|
2023
Q4 | $3.27M | Buy |
142,470
+120,723
| +555% | +$2.77M | 0.01% | 877 |
|
|
2023
Q3 | $363K | Sell |
21,747
-142,753
| -87% | -$2.38M | ﹤0.01% | 1525 |
|
|
2023
Q2 | $4.54M | Sell |
164,500
-1,201,580
| -88% | -$33.2M | 0.01% | 900 |
|
|
2023
Q1 | $31.4M | Sell |
1,366,080
-88,366
| -6% | -$2.03M | 0.07% | 275 |
|
|
2022
Q4 | $15.9M | Buy |
1,454,446
+639,720
| +79% | +$6.98M | 0.04% | 493 |
|
|
2022
Q3 | $6.87M | Buy |
814,726
+350,669
| +76% | +$2.96M | 0.02% | 1025 |
|
|
2022
Q2 | $3.67M | Buy |
+464,057
| New | +$3.67M | 0.01% | 1333 |
|
|
2021
Q2 | – | Sell |
-86,691
| Closed | -$2.25M | – | 2458 |
|
|
2021
Q1 | $2.25M | Sell |
86,691
-30,103
| -26% | -$780K | 0.01% | 1095 |
|
|
2020
Q4 | $2.35M | Buy |
+116,794
| New | +$2.35M | 0.01% | 803 |
|
|
2019
Q3 | – | Sell |
-17,799
| Closed | -$216K | – | 1840 |
|
|
2019
Q2 | $216K | Buy |
+17,799
| New | +$216K | ﹤0.01% | 1201 |
|